Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|
February 12, 2011
Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease
Dagmar E Ehrnhoefer, Liza Sutton, Michael R Hayden
Trends in Neurosciences
|
October 25, 2011
Caspase-6 and neurodegeneration
Rona K Graham, Dagmar E Ehrnhoefer, Michael R Hayden
Nature Reviews. Drug Discovery
|
October 22, 2011
Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development
Dagmar E Ehrnhoefer, Bibiana K Y Wong, Michael R Hayden
Disease Models & Mechanisms
|
March 5, 2009
Mouse models of Huntington disease: variations on a theme
Dagmar E Ehrnhoefer, Stefanie L Butland, Mahmoud A Pouladi, et al.
Trends in Neurosciences
|
October 6, 2014
Autophagy in Huntington disease and huntingtin in autophagy
Dale D O Martin, Safia Ladha, Dagmar E Ehrnhoefer, et al.
Experimental Neurology
|
June 15, 2016
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons
Dagmar E Ehrnhoefer, Nicholas S Caron, Yu Deng, et al.
Cell Death Discovery
|
March 22, 2018
Constitutive ablation of caspase-6 reduces the inflammatory response and behavioural changes caused by peripheral pro-inflammatory stimuli
Safia Ladha, Xiaofan Qiu, Lorenzo Casal, et al.
Human Molecular Genetics
|
January 25, 2015
A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits
Israel Aharony, Dagmar E Ehrnhoefer, Adi Shruster, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 14, 2010
EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity
Jan Bieschke, Jenny Russ, Ralf P Friedrich, et al.
Nature Structural & Molecular Biology
|
May 31, 2008
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E Ehrnhoefer, Jan Bieschke, Annett Boeddrich, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|
February 12, 2011
Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease
Dagmar E Ehrnhoefer, Liza Sutton, Michael R Hayden
Trends in Neurosciences
|
October 25, 2011
Caspase-6 and neurodegeneration
Rona K Graham, Dagmar E Ehrnhoefer, Michael R Hayden
Nature Reviews. Drug Discovery
|
October 22, 2011
Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development
Dagmar E Ehrnhoefer, Bibiana K Y Wong, Michael R Hayden
Disease Models & Mechanisms
|
March 5, 2009
Mouse models of Huntington disease: variations on a theme
Dagmar E Ehrnhoefer, Stefanie L Butland, Mahmoud A Pouladi, et al.
Trends in Neurosciences
|
October 6, 2014
Autophagy in Huntington disease and huntingtin in autophagy
Dale D O Martin, Safia Ladha, Dagmar E Ehrnhoefer, et al.
Experimental Neurology
|
June 15, 2016
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons
Dagmar E Ehrnhoefer, Nicholas S Caron, Yu Deng, et al.
Cell Death Discovery
|
March 22, 2018
Constitutive ablation of caspase-6 reduces the inflammatory response and behavioural changes caused by peripheral pro-inflammatory stimuli
Safia Ladha, Xiaofan Qiu, Lorenzo Casal, et al.
Human Molecular Genetics
|
January 25, 2015
A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits
Israel Aharony, Dagmar E Ehrnhoefer, Adi Shruster, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 14, 2010
EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity
Jan Bieschke, Jenny Russ, Ralf P Friedrich, et al.
Nature Structural & Molecular Biology
|
May 31, 2008
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E Ehrnhoefer, Jan Bieschke, Annett Boeddrich, et al.
Page
of 4